Multiple sclerosis:: recent developments in neuropathology, pathogenesis, magnetic resonance imaging studies and treatment

被引:102
作者
Lucchinetti, C
Brück, W
Noseworthy, J
机构
[1] Mayo Clin & Mayo Fdn, Dept Neurol, Rochester, MN 55905 USA
[2] Humboldt Univ, Charite, Dept Neuropathol, Berlin, Germany
关键词
D O I
10.1097/00019052-200106000-00002
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The cause of multiple sclerosis is generally considered to be entirely T cell mediated. However, recent reports of studies in a variety of animal models of inflammatory demyelinating disease, coupled with detailed pathological analysis and neuroimaging studies of multiple sclerosis patients, indicate that the events involved in the formation of the multiple sclerosis lesion may be more complicated. This complex pathogenesis is reflected in the variable response of multiple sclerosis patients to immunomodulatory therapy. Curr Opin Neurol 14:259-269. (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码:259 / 269
页数:11
相关论文
共 132 条
[51]   SIGNIFICANCE OF PERIVASCULAR INFILTRATIONS IN MULTIPLE-SCLEROSIS [J].
GUSEO, A ;
JELLINGER, K .
JOURNAL OF NEUROLOGY, 1975, 211 (01) :51-60
[52]  
Helms G, 2000, MAGNET RESON MED, V43, P102, DOI 10.1002/(SICI)1522-2594(200001)43:1<102::AID-MRM12>3.0.CO
[53]  
2-I
[54]   Biotechnological agents for the immunotherapy of multiple sclerosis - Principles, problems and perspectives [J].
Hohlfeld, R .
BRAIN, 1997, 120 :865-916
[55]   Correlations between clinical and MRI involvement in multiple sclerosis:: assessment using T1, T2 and MT histograms [J].
Iannucci, G ;
Minicucci, L ;
Rodegher, M ;
Sormani, MP ;
Comi, G ;
Filippi, M .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1999, 171 (02) :121-129
[56]   Quantitative brain volumetric analysis from patients with multiple sclerosis: a follow-up study [J].
Inglese, M ;
Rovaris, M ;
Giacomotti, L ;
Mastronardo, G ;
Comi, MG ;
Filippi, M .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1999, 171 (01) :8-10
[57]   Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. [J].
Jacobs, LD ;
Beck, RW ;
Simon, JH ;
Kinkel, RP ;
Brownscheidle, CM ;
Murray, TJ ;
Simonian, NA ;
Slasor, PJ ;
Sandrock, AW .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (13) :898-904
[58]   Brain atrophy as a surrogate marker in MS - Faster, simpler, better? [J].
Jagust, WJ ;
Noseworthy, JH .
NEUROLOGY, 2000, 54 (04) :782-783
[59]   Cortical deficits in multiple sclerosis on the basis of subcortical lesions [J].
Jeffery, DR ;
Absher, J ;
Pfeiffer, FE ;
Jackson, H .
MULTIPLE SCLEROSIS, 2000, 6 (01) :50-55
[60]   Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years [J].
Johnson, KP ;
Brooks, BR ;
Ford, CC ;
Goodman, A ;
Guarnaccia, J ;
Lisak, RP ;
Myers, LW ;
Panitch, HS ;
Pruitt, A ;
Rose, JW ;
Kachuck, N ;
Wolinsky, JS .
MULTIPLE SCLEROSIS JOURNAL, 2000, 6 (04) :255-266